Zobrazeno 1 - 10
of 1 986
pro vyhledávání: '"Access to Medicines"'
Autor:
de Sousa Neves D, Jayasekar Zürn S, Khuc-Bilon T, Rendler-Garcia M, Martei YM, Krishnamurthy Reddiar S
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 1609-1616 (2024)
Diogo de Sousa Neves,1,2 Shalini Jayasekar Zürn,2 Thuy Khuc-Bilon,2 Melissa Rendler-Garcia,2 Yehoda M Martei,3 Sumithra Krishnamurthy Reddiar2 1Independent Global Health Consultant, Paris, Ile-de-France, France; 2ATOM Coalition Secretariat, Union fo
Externí odkaz:
https://doaj.org/article/5724d954bd4644c8ac186d39363c984d
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract In Brazil, the judicialization of public health for access to medications has resulted in significant challenges to the management of public policies, especially at the municipal level. To evaluate the profile of drug litigations against the
Externí odkaz:
https://doaj.org/article/c4dc53dac2a04272af79a32708fb24cf
Autor:
Prashant Yadav
Publikováno v:
Health Systems & Reform, Vol 10, Iss 2 (2024)
Well-functioning supply chains for medicines and other health products are vital for a health system’s goals of ensuring access, quality, and efficiency. However, in several countries the performance of government-run supply chains for health produ
Externí odkaz:
https://doaj.org/article/d90065f6100e486890175646ed95b1b9
Autor:
Kathiaja Miranda Souza, Nora Giron, Juliana Vallini, Kemel Hallar, Pedro Ordunez, Andres Rosende, Baudelio Ramírez Loya, David Debrott Sánchez, Christoper Lim
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Introduction Hypertension significantly impacts the global cardiovascular disease burden, presenting a pronounced challenge within Latin America and the Caribbean. The Pan American Health Organization's (PAHO) HEARTS initiative endeavours to meet thi
Externí odkaz:
https://doaj.org/article/3a0cbb04ad364374a846a322029d0837
Autor:
Iris R. Joosse, Hendrika A. van den Ham, Aukje K. Mantel-Teeuwisse, Velisha A. Perumal-Pillay, Fatima Suleman
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background We sought to identify what barriers and facilitators determine current perceived access to childhood cancer care in South Africa through in-depth interviews with stakeholders in South Africa’s public and private sectors.Methods Qualitati
Externí odkaz:
https://doaj.org/article/dc634301bd164c87828ed43d0b76bdd0
Publikováno v:
Global Public Health, Vol 19, Iss 1 (2024)
Pharmaceutical sector corruption undermines patient access to medicines by diverting public funds for private gain and exacerbating health inequities. This paper presents an analysis of UN Convention Against Corruption (UNCAC) compliance in seven cou
Externí odkaz:
https://doaj.org/article/b7cc1abbab2e4c07a47d11e0f3e9c824
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
ABSTRACTBackground: Conscientious objection (CO) in healthcare is a controversial topic. Some perceive CO as freedom of conscience, others believe their professional duty-of-care overrides personal-perspectives. There is a paucity of literature perta
Externí odkaz:
https://doaj.org/article/276a070c4beb4191b7a8c39999db59e0
Autor:
Kunle Rotimi, Babatunde Fagbemi, Ademola Joshua Itiola, Taiwo Ibinaiye, Adaeze Aidenagbon, Chrysantus Dabes, Ahmed Aminu Biambo, Azuka Iwegbu, Sarah Onabajo, Chibuzo Oguoma, Olusola Oresanya
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background To guarantee uninterrupted service delivery, quality-assured products must be affordable and continuously available across all sectors, including the private sector, which provides more than 60% of healthcare services in Nigeria. We invest
Externí odkaz:
https://doaj.org/article/52f0fbd3bcb242509d67a6948c9cd24d
Autor:
Green, Duncan, author
Publikováno v:
How Change Happens, 2024.
Externí odkaz:
https://doi.org/10.1093/oso/9780198899952.003.0010
Publikováno v:
Global Health Research and Policy, Vol 9, Iss 1, Pp 1-6 (2024)
Abstract Gaps in access to quality essential medicines remain a major impediment to the effective care of children with cancer in low-and middle-income countries (LMICs). The World Health Organization reports that less than 30% of LMICs have consiste
Externí odkaz:
https://doaj.org/article/41dc3b74d0f74bf69371b53812cc859f